Dr. Matthew Davids

Dr. Matthew Davids

Associate Director, Center for CLL
Dana-Farber Cancer Institute

Dr. Matthew Davids is an attending physician in the Lymphoma Program of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute, an Assistant Professor of Medicine at Harvard Medical School and the Associate Director of the Dana-Farber CLL Center.

Dr. Davids has an active translational research program in chronic lymphocytic leukemia (CLL), studying Bcl-2 biology in his laboratory and leading clinical trials to evaluate novel therapeutic strategies in patients with CLL and other hematologic malignancies.

Diagnosis

The IGHV Mutation is Key to CLL Prognosis

Treatment

An Oral Medicine for People With Relapsed CLL: Idelalisib

Treatment

What is CAR-T Therapy?

Treatment

Initial Treatment Options for CLL Depend on Age

Treatment

What are the Stages of CLL?

Later Stage

Do I Need A Stem Cell Transplant For CLL?

Later Stage

CLL is Not Considered Curable So Treatment May Resume Years Later

Later Stage

Physical Symptoms Are Usually Seen in Advanced Stages of CLL

Diagnosis

Tests That Can Inform the Prognosis of CLL

Treatment

Clinical Trials Test State-of-the-Art Cancer Treatments

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.